GSK to leverage the Cell and Gene Therapy Catapult’s facility in Stevenage
British drugmaker to expand its clinical manufacturing capacity for cell and gene therapy
11th March 2021
Latest news
Pharma, comms and patient group leaders join judging panel for Patient Partnership Index 2021
Senior leaders from UK and European pharma have come together to judge the Patient Partnership Index 2021
11th March 2021
Researchers identify inflammatory protein associated with severe COVID-19
Cytokine GM-CSF found at higher levels in people who progressed to severe COVID-19
11th March 2021
MHRA authorises Lilly’s RET inhibitor Retsevmo
Oral therapy approved for RET-driven advanced lung and thyroid cancers
11th March 2021
Roche withdraws US indication for Tecentriq in bladder cancer
Tecentriq failed to improve overall survival in post-marketing study
10th March 2021
MHRA green light for DemeRx’s opioid use disorder trial
Phase I portion of the trial will be conducted at the Manchester clinical unit of MAC Clinical Research
10th March 2021
Novartis’ canakinumab fails to improve overall survival in lung cancer trial
Two additional Phase III trials will continue to investigate canakinumab
10th March 2021
CQC publishes new agreement with Equality and Human Rights Commission
Agreement aims to safeguard rights of people receiving health and social care in England
10th March 2021
Researchers identify early changes in BRCA1-positive breast cells
New study suggests BRCA1 breast cells undergo changes before becoming cancerous
9th March 2021
NICE rejects AZ’s Lynparza for metastatic prostate cancer
Appraisal committee highlighted uncertainties in the clinical evidence for PARP inhibitor
9th March 2021
Parkinson’s UK invests £1.2m in drug design project
One-year project aims to refine molecule for potential drug development
9th March 2021
SMC accepts Zolgensma and Rozlytrek for use by NHS Scotland
Both medicines reviewed through the SMC's PACE process
9th March 2021
INTCR 2021 invites the best and brightest from all corners of the globe to enter
The PharmaTimes International Clinical Researcher of the Year is calling on the most talented clinical researchers to try their hand and reap the rewards in the 2021 competition.
8th March 2021
Gilead’s HIV therapy Biktarvy demonstrates long-term sustained efficacy
Data from two Phase III studies demonstrated durable viral suppression in HIV-1 patients
8th March 2021
CHMP issues positive opinion for Lilly’s COVID-19 antibodies
Advice recommends the use of bamlanivimab alone and combined with etesevimab to treat COVID-19
8th March 2021
